Keith Hawton1, Daniel Zahl, Rosamund Weatherall. 1. Centre for Suicide Research, University Department of Psychiatry, Warneford Hospital, Oxford, UK. keith.hawton@psych.ox.ac.uk
Abstract
BACKGROUND: Deliberate self-harm (DSH) is the strongest risk factor for future suicide. Up-to-date information on the extent of risk is lacking. AIMS: To investigate the risk of suicide after DSH during a long follow-up period. METHOD: A mortality follow-up study to 2000 was conducted on 11 583 patients who presented to hospital after DSH between 1978 and 1997. Data were obtained from a general hospital DSH register in Oxford and the Office for National Statistics, and from equivalent mortality registers in Scotland and Northern Ireland. RESULTS: Three hundred patients had died by suicide or probable suicide. The risk in the first year of follow-up was 0.7% (95% CI 0.6-0.9%), which was 66 (95% CI 52-82) times the annual risk of suicide in the general population. The risk after 5 years was 1.7%, at 10 years 2.4% and at 15 years 3.0%. The risk was far higher in men than in women (hazard ratio 2.8,95% CI 2.2-3.6). In both genders it increased markedly with age at initial presentation. CONCLUSIONS: Following DSH there is a significant and persistent risk of suicide, which varies markedly between genders and age groups. Reduction in the risk of suicide following DSH must be a key element in national suicide prevention strategies.
BACKGROUND: Deliberate self-harm (DSH) is the strongest risk factor for future suicide. Up-to-date information on the extent of risk is lacking. AIMS: To investigate the risk of suicide after DSH during a long follow-up period. METHOD: A mortality follow-up study to 2000 was conducted on 11 583 patients who presented to hospital after DSH between 1978 and 1997. Data were obtained from a general hospital DSH register in Oxford and the Office for National Statistics, and from equivalent mortality registers in Scotland and Northern Ireland. RESULTS: Three hundred patients had died by suicide or probable suicide. The risk in the first year of follow-up was 0.7% (95% CI 0.6-0.9%), which was 66 (95% CI 52-82) times the annual risk of suicide in the general population. The risk after 5 years was 1.7%, at 10 years 2.4% and at 15 years 3.0%. The risk was far higher in men than in women (hazard ratio 2.8,95% CI 2.2-3.6). In both genders it increased markedly with age at initial presentation. CONCLUSIONS: Following DSH there is a significant and persistent risk of suicide, which varies markedly between genders and age groups. Reduction in the risk of suicide following DSH must be a key element in national suicide prevention strategies.
Authors: Anne E Rhodes; Jennifer Bethell; Julie Spence; Paul S Links; David L Streiner; R Liisa Jaakkimainen Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2008-05-29 Impact factor: 4.328
Authors: S Zanone Poma; S Vicentini; F Siviero; A Grossi; E Toniolo; S Cocchio; V Baldo; Diego De Leo Journal: Community Ment Health J Date: 2014-02-22
Authors: Vincent C H Chen; Jen-Yu Chou; Ti-Chen Hsieh; Hung-Jung Chang; Charles T C Lee; Michael Dewey; Robert Stewart; Happy K L Tan Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-04-06 Impact factor: 4.328
Authors: Amanda S Newton; Michele P Hamm; Jennifer Bethell; Anne E Rhodes; Craig J Bryan; Lisa Tjosvold; Samina Ali; Erin Logue; Ian G Manion Journal: Ann Emerg Med Date: 2010-04-09 Impact factor: 5.721